Calgary, Alberta – TheNewswire - June 12, 2023 - nDatalyze Corp. (“NDAT” or the “Corporation”) (CSE:NDAT) (OTC:NDATF) provides an operational update. The Corporation announces that it has completed its gathering of marketing statistics from California and New York States for the consumer application ("B2C") of YMI. The Corporation continues its search for a qualified third-party to conduct a clinical trial and/or peer review of the B2B aspect of the YMI application, which aspect has been expanded to include first responders, law enforcement, government and regulatory agencies, security forces, airlines and insurance risk-assessment markets. The purpose of this process is to determine economic success probabilities of the B2C vs. B2B aspects of the YMI predictive mental health application. The Corporation will provide updates as the search progresses.

About YMI: YMI uses evidence-based, objective data from whole life experiences to predict individual mental states over time and applies this knowledge towards a fuller understanding of how mental health develops and to improve mental wellbeing. After registering at ymihealth.ca (https://ymihealth.ca) users gain access to a private, in-depth survey that applies machine-learning using a person’s genetic expressions, childhood environment, habits, phobias, lived experiences and lifestyle. Upon completion of the questionnaire YMI generates a personalized graphic report predicting a person’s predisposition toward seven mental conditions including anxiety, depression, post-traumatic stress disorder, obsessive compulsive disorder, alcoholism, and personality disorders, both current and forward in time. The downloadable report may be used for reference as the user considers changes to their lifestyle that may help improve their mental wellbeing and mental health journey.

About nDatalyze Corp.: nDatalyze Corp. generates technology-based, health-related solutions. It’s machine-learning processed, online consumer mental health application known as “YMI” is based on the Corporation’s proprietary Reference Database consisting of >1200 biometric records complete with associated electroencephalogram (“EEG”) data. YMI has only recently begun its initial staged launch and accordingly the Corporation cannot accurately predict if or when this application will become a profit generator.

For Further Information, Please Contact:

James Durward, President and CEO

Telephone: (403) 689-3901

Email: jimd@ndatalyze.com    YMI Website: https://ymihealth.ca

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

The information in this news release includes certain information and statements about management's view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Corporation believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward-looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.